These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8494388

  • 1. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Lawrence T, Rotstein C, Beam TR, Gorzynski EA, Amsterdam D.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):896-900. PubMed ID: 8494388
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV, Dholakia N, Ho DH, LeBlanc B, Dvorak T, Streeter H.
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D, Mildvan D, Handwerger S.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of teicoplanin against gram-positive cocci.
    Allouch P, Pina P, Chaplain C, Delarbre JM, Geffroy F, Grasmick CP, Marcolin M, Morel A, Pangon B, Rio Y, Sédaillan A.
    Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin.
    Grüneberg RN, Hryniewicz W.
    Int J Antimicrob Agents; 1998 Nov; 10(4):271-7. PubMed ID: 9916900
    [Abstract] [Full Text] [Related]

  • 11. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
    Gorzynski EA, Amsterdam D, Beam TR, Rotstein C.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2019-22. PubMed ID: 2532875
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 Nov; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 13. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.
    Drugs; 1997 Nov; 54 Suppl 6():11-20. PubMed ID: 9474477
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [Abstract] [Full Text] [Related]

  • 15. Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
    Shonekan D, Handwerger S, Mildvan D.
    J Antimicrob Chemother; 1997 Mar; 39(3):405-9. PubMed ID: 9096191
    [Abstract] [Full Text] [Related]

  • 16. Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
    Hardy D, Amsterdam D, Mandell LA, Rotstein C.
    Antimicrob Agents Chemother; 2000 Mar; 44(3):802-5. PubMed ID: 10681365
    [Abstract] [Full Text] [Related]

  • 17. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA, Hamilton-Miller JM, Brumfitt W.
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Biavasco F, Manso E, Varaldo PE.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):195-7. PubMed ID: 1826593
    [Abstract] [Full Text] [Related]

  • 19. Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
    Jones RN, Stilwell MG, Sader HS, Fritsche TR, Goldstein BP.
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):149-53. PubMed ID: 16426793
    [Abstract] [Full Text] [Related]

  • 20. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F, Vignaroli C, Lupidi R, Manso E, Facinelli B, Varaldo PE.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.